SCHEMBL9511758

SCHEMBL9511758

CCCCCCC[C@H]1CC[C@H](c2ccc(C#Cc3ccc(OC)cc3)cc2)CC1

nearest known ligand 0.46

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 1/20 0.46
SPHK1 Q9NYA1 3/20 0.40
CYP2C9 P11712 1/20 0.39
APP P05067 2/20 0.39
GRM2 Q14416 1/20 0.39
MAPT P10636 2/20 0.38
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
ALDH1A1 P00352 1/20 0.38
LMNA P02545 1/20 0.38
MAPK1 P28482 1/20 0.38
RAB9A P51151 1/20 0.38
GAA P10253 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26347319 0.99 DRD2 (0.47) DRD2SPHK1CYP2C9APPGRM2
SCHEMBL9508804 0.99 DRD2 (0.47) DRD2SPHK1CYP2C9APPGRM2
SCHEMBL9509006 0.95 DRD2 (0.48) DRD2CYP2C9APPMAPTMEN1
SCHEMBL19722184 0.92 DRD2 (0.52) DRD2SPHK1CYP2C9GRM2MAPT
SCHEMBL21321988 0.92 DRD2 (0.52) DRD2SPHK1CYP2C9GRM2MAPT
SCHEMBL9509338 0.91 DRD2 (0.45) DRD2CYP2C9APPMAPTMEN1
SCHEMBL9511338 0.91 RAB9A (0.46) SPHK1CYP2C9LMNARAB9A
SCHEMBL9743813 0.91 SLC6A2 (0.38) DRD2SPHK1CYP2C9GRM2MAPT
SCHEMBL9743818 0.91 SLC6A2 (0.38) DRD2SPHK1CYP2C9GRM2MAPT
SCHEMBL9742806 0.91 SLC6A2 (0.38) DRD2SPHK1CYP2C9GRM2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0308438-B1 LIQUID CRYSTAL PHASE CONTAINING TOLANES MERCK PATENT GmbH (DE) 1993-09-29 EP disclosed